glp 1 for 17 year old GLP-1 Teens: Safety, Age Limits & Biomarker Context – PlexusDx Wegovy® for Adolescents with Obesity
Description
Key Takeaways: Retatrutide (Triple-G Peptide) is a next-generation, triple-hormone GLP-1/GIP/glucagon medication currently in clinical trials, showing record-breaking fat-loss potential
How to use At present, GLP-1 receptor agonists are available as weekly or daily injections, and in some cases as oral tablets
Common side effects include gastrointestinal symptoms like nausea, vomiting, and diarrhea
You may notice less GI discomfort around meals, though individual responses vary.*
Some are approved for weight loss, while others are given for other reasons but are nonetheless effective for weight loss
doi: 10.1159/000509583 94 ChouchaniETKazakLSpiegelmanBM
